Secukinumab Sustains Individual Clinical Responses Over Time in Patients with Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial. J of Skin [Internet]. 2018 Feb. 23 [cited 2026 Apr. 17];2(S1):S21. Available from: https://skin.dermsquared.com/skin/article/view/293